Abstract
Withania somnifera (Ashwagandha) is a shrub plant from the family of Solanaceae and widely used by practitioners in the folk medicines as immune boosting agent. The medicinal properties of plants have been attributed due to the presence of steroidal lactones called as withanolides. Withanolides are a group of highly oxygenated steroids derived from a C28 ergostane skeleton and have attracted significant scientific interest due to their complex structural features and multiple bioactivities. Last one decade’s more than 130 new natural withanolides were isolated from Withania spp., and the scientist from the different field demonstrated that Ashwagandha possesses antioxidant, anti-inflammatory, antitumor, antimicrobial properties. This chapter briefly reviews the drug-likeness activity of withanolides against antibacterial, antifungal, antiparasitic diseases and more focussed on antileishmanial and immunomodulatory activities of withanolides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal R, Diwanay S, Patki P, Patwardhan B (2012) Studies on immunomodulatory activity of Withania somnifera (Ashwagandha). J App Pharm Sci 2:170–175
Alam N, Hossain M, Ma M, Sa S, Gan SH, Khalil MI (2012) Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complement Altern Med 12:175
Amuamuta A, Na-Bangchang K (2015) A review of ethnopharmacology of the commonly used antimalarial herbal agents for traditional medicine practice in Ethiopia. Afr J Pharm Pharmacol 9:615–627
Anjaneyulu ASR, Satyanarayana Rao D (1997) New withanolides from the roots of Withania somnifera. Indian J Chem 36:424–433
Arora S, Dhillon RG, Nagpal A (2004) The in vitro antibacterial/ synergistic activities of Withania somnifera extracts. Fitoterapia 75:385–388
Atta-ur-Rahman, Choudhary M (1993) New withanolides from Withania somnifera spp. J Nat Prod 56:1000–1006
Bani S, Gautam M, Sheikh FA, Khan B, Satti NK, Suri KA, Qazi GN, Patwardhan B (2006) Selective Th-1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry. J Ethnopharmacol 107:107–115
Bansod S, Rai M (2008) Antifungal activity of essential oils from Indian medicinal plants against human pathogenic Aspergillus fumigatus and A. niger. World J Med Sci 3:81–88
Bhattacharya SK, Goel RK, Kaur R, Ghosal S (1987) Antistress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res 1:32–39
Bogale M, Petros B (1996) Evaluation of the antimalarial activity of some Ethiopian traditional medicinal plants against P. falciparum in vitro. SINET 19:233–243
Bokaeian M, Fakheri BA, Nejad NM, Zarei H, Saeidi S, Mohasseli T (2015) The effect of Withania somnifera extract on drug resistant strains of Escherichia coli. Int J Inf Secur 2:e23036
Budhiraja RD, Sudhir S (1987) Review of biological activity of Withanolides. J Sci Ind Res 46:488–491
Calla-Magarinos J, Quispe T, Gimenez A, Freysdottir J, Troye-Blomberg M, Fernandez C (2013) Quinolinic alkaloids from Galipea Longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice. Scand J Immunol 77:30–38
Chandrasekaran S, Dayakar A, Veronica J, Sundar S, Maurya R (2013) An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. Parasitol Int 62:253–261
Chandrasekaran S, Veronica J, Dayakar A, Sundar S, Maurya R (2015) Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani. J Enzyme Inhib Med Chem 25:1–9
Chandrasekaran S, Veronica J, Sundar S, Maurya R (2017) Alcoholic fractions F5 and F6 from Withania somnifera leaves show a potent Antileishmanial and Immunomodulatory activities to control experimental Visceral Leishmaniasis. Front Med 4:55
Chatterjee S, Srivastava S, Khalid A, Singh N, Sangwan RS, Sidhu OP, Raja R, Khetrapal CL, Tuli R (2010) Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extract. Phytochemistry 71:1085–1094
Chen L, He H, Qiu F (2011) Natural withanolides: an overview. Nat Prod Rep 28:705–740
Choudhary MI, Dur-E-Shanhwar Z, Parveen A, Jabbar IA, Atta-ur-Rahman (1995) Antifungal steroidal lactones from Withania coagulance. Phytochemistry 40:1243–1246
Chouhan G, Islamuddin M, Sahal D, Afrin F (2014) Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis. Front Immunol 5:193
Chowdhury S, Mukherjee T, Mukhopadhyay R, Mukherjee B, Sengupta S, Chattopadhyay S, Jaisankar P, Roy S, Majumder HK (2012) The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice. EMBO Mol Med 4:1126–1143
Dame Z, Petros B, Mekonnen Y (2013) Evaluation of anti-Plasmodium berghei activity of crude and column fractions of extracts from Withania somnifera. Turk J Biol 37:147–150
Datta S, Kumar Pal NK, Nandy AK (2011) Inhibition of the emergence of multi drug resistant Staphylococcus aureus by Withania somnifera root extracts. Asian Pac J Trop Med 4:917–920
Davis L, Kuttan G (1998) Suppressive: effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol 62:209–214
Davis L, Kuttan G (2000) Effect of Withania somnifera on cyclophosphamide induced urotoxicity. Cancer Lett 148:4–17
Dhalla NS, Gupta KC, Sastry MS, Malhotra CL (1961) Comparative studies of Withania somnifera. Indian J Pharmacol 23:126
Dhuley JN (1997) Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 58:15–20
Dhuley JN (1998) Effect of Asgand on lipid peroxidation in stress induced animals. J Ethnopharmacol 7:173–178
Dikasso D, Mekonnen E, Debella A (2006) Antimalarial activity of Withania somnifera L. Dunal extracts in mice. J Ethiop Med 44:279–285
El-Boshy ME, Abdalla OM, Risha A, Moustafa F (2013) Effect of Withania somnifera extracts on some selective biochemical, hematological, and immunologi- cal parameters in guinea pigs experimental infected with E. coli. ISRN Vet Sci 2013:6
Gamboa-Leon R, Vera-Ku M, Peraza-Sanchez SR, Ku-Chulim C, Horta-Baas A, Rosado-Vallado M (2014) Antileishmanial activity of a mixture of Tridax procumbens and Allium sativum in mice. Parasite 21:15
Ghosal S, Kaur R, Srivastava RS (1988) Sitoindosides IX and X, new glycowithanolides from W. somnifea. Ind J Nat Pr 4:12–13
Glotter E, Kirson I, Abraham A, Lavis D (1973) Constituents of Withania somnifera (Dunal) XIII- The Withanolides of chemotype III. Tetrahedron Lett 29:1353–64
Grover A, Shandilya A, Bisaria VS, Sundar D (2010) Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes. BMC Genomics 11(Suppl 4):S15
Grover A, Agrawal V, Shandilya A, Bisaria VS, Sundar D (2011) Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A. BMC Bioinformatics 12(Suppl 13):S22
Grover A, Singh R, Shandilya A, Priyandoko D, Agrawal V, Bisaria VS, Wadhwa R, Kaul SC, Sundar D (2012) Ashwagandha derived withanone targets TPX2-Aurora A Complex: computational and experimental evidence to its anticancer activity. Plos One 7(1):e30890
Grover A, Katiya SP, Jeyakanthan J, Dubey VK, Sundar D (2012) Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera. BMC Genomics 13(Suppl 7):S20
Halamova K, Kokoska L, Polesny Z, Macakova K, Flesar J, Rada V (2013) Selective in vitro growth inhibitory effect of Withania a somnifera on human pathogenic bacteria and bifidobacteria. Pak J Bot 45:667–670
Heyman HM, Hussein AA, Meyer JJM, Lall N (2009) Antibacterial activity of South African medicinal plants against methicillin resistant Staphylococcus aureus. Pharm Biol 47:67–71
Jaffer HJ, Jawad ALM, Saber HS, Al-Naib A (1988) Evaluation of antimicrobial activity of Withania somnifera extracts. Fitoterapia 59:497–500
Kaur S, Chauhan K, Sachdeva H (2014) Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus. J Med Microbiol 63:1328–1338
Khan FZ, Saeed MA, Alam M, Chaudhary AR, Ismail M (1993) Biological studies of indigenous medicinal plants III Phytochemical and antimicrobial studies on the non alkaloidal constitutes of some solanaceous fruit. Fac Pharmacy Gazi Univ 10:105–16
Khan B, Ahmad SF, Bani S, Kaul A, Suri KA, Satti NK, Athar M, Qazi GN (2006) Augmentation and proliferation of T lymphocytes and Th-1 cytokines by Withania somnifera in stressed mice. Int Immunopharmacol 6:1394–1403
Khan S, Malik F, Suri KA, Singh J (2009) Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity. Vaccine 27:6080–6087
Kirson I, Glotter E (1980) 14 a-hydroxy steroids from W somnifera (L) Dunal. J Chem Res Synop 10:338–339
Kirson I, Glotter E, Abraham A, Lavis D (1969) Two new constituents of W somnifera (L) Dunal. Indian type. Isr J Chem (proceedings) 15
Kirson I, Glotter E, Abraham A, Lavis D (1970) Constituents of Withania somnifera. Dunal XI the structure of three new withnolides. Tetrahedron 26:2209–2215
Kirson I, Glotter E, Lavis D, Abraham A (1971) Constituents of Withania somnifera Dunal XII the withanolides of an Indian Chemotype. J Chem Soc (Org) 2032–2044
Kohlumnezer S, Krupinska J (1963) Isolation of an antibiotic substance unsaturated lactine, m.P. 159- 60oC from the leaves of W somnifera. Disseratones Pharm 11:501–506
Kurup PA (1956) The antibacterial principle of the leaves of Withania somnifera. Curr Sci Bangalore 25:57–58
Kurup PA (1958) The antibacterial principle of Withania somnifera. I. Isolation and antibacterial activity. Antibiot Chemother 8:511–515
Kundu AB, Mukerjee A, Dey AK (1976) A new Withanolide from the seeds of Withania somnifera. Indian J Chem 14B:434–5
Lavie D, Glotter E, Shvo Y (1965) Constituents of Withania somnifera Dun. Part IV. The structure of withaferin A J Chem Soc 30:7517–7531
Lavie D, Kirson I, Glotter E (1968) Constituents of Dun. Part X the structure of Withanolide D. Israel J Chem 6(5):671–678
Lavie D, Kirson I, Abraham A (1972) Steroidal lactones of W. somnifera. Harokaech. Haivri 14:362–368
Lavie D, Glotter E, Kirson I, Abraham A (1975) Isolation of Withanolide D from W.somnifera chemotype II. Phytochemistry 14:189–94
Mahesh B, Satish S (2008) Antimicrobial activity of some important medicinal plant against plant and human pathogens. World J Agric Sci 4:839–843
Majumdar DN (1955) Withania somnifera Dunal, Part II, alkaloidal constituents and their chemical characterization. Ind J Pharmaco 17:158–161
Malik F, Kumar A, Bhushan S, Mondhe DM, Pal HC, Sharma R, Khajuria A, Singh S, Singh G, Saxena AK, Suri KA, Qazi GN, Singh J (2009) Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. Eur J Cancer 45:1494–1509
Menssen HG, Stapel G (1973) A C28-steroidlacton from the roots of Withania somnifera. Planta Med 24:8–12
Mir BA, Koul S, Kumar A, Sushant S, Kaul MK, Soodan AS (2012) Reproductive behaviour and breeding system of wild and cultivated types of Withania somnifera (L.) Dunal. J Med Plants Res 6(5):754–762
Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazon J (2009) Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 14:2373–2393
Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Re 5:334–346
Namdeo AG, Sharma A, Yadav KN, Gawande R, Mahadik KR, Lopez-Gresa MP, Kim HK, Choi YH, Verpoorte R (2011) Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy. Planta Med 17:1958–1964
Oh JH, Lee TJ, Kim SH, Choi YH, Lee SH, Lee JM, Kim YH, Park JW, Know TK (2008) Induction of apoptosis by withaferin A in human leukaemia U937 cells through downregulation of Akt phosphorylation. Apoptosis 13:1494–1504
Owais M, Sharad KS, Shehbaz A, Saleemuddin M (2005) Antibacterial efficacy of Withania somnifera (Ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 12:229–235
Pandit S, Chang KW, Jeon JG (2013) Effects of Withania somnifera on the growth and virulence properties of Streptococcus mutans and Streptococcus sobrinus at sub-MIC levels. Anaerobe 19:1–8
Polesny Z, Flesar J, Jankovska I, Rada V, Kokoska L (2008) Selective in vitro inhibitory effect of Withania somnifera extract on growth of human pathogenic bacteria and bifidobacteria. First European Food Congress ´08, Ljubljana, Slovenia, Abstract p30
Pramanick S, Roy A, Ghosh S, Majumder H, Mukhopadhyay S (2008) Withanolide Z, a New Chlorinated Withanolide from Planta. Medica 74(14):1745–1748
Pretorius E, Oberholzer HM, Becker PJ (2009) Comparing the cytotoxic potential of Withania somnifera water and methanol extracts. Afr J Trad CAM 6:275–280
Rajendran NK, Ramakrishnan J (2009) In vitro evaluation of antimicrobial activity of crude extracts of medicinal plants against multi drug resistant pathogens. Biyoloji Bilimleri Araptyrma Dergisi 2:97–101
Rasool M, Varalakshmi P (2006) Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: an in vivo and in vitro study. Vasc Pharmacol 44:406–410
Sachdeva H, Sehgal R, Kaur S (2013) Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitol Res 112:2269–2280
Sen N, Banerjee B, Das BB, Ganguly A, Sen T, Pramanik S, Mukhopadhyay S, Majumder HK (2007) Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex. Cell Death Differ 14:358–367
Sethi PD, Sharma KB, Subramanian Sankara S (1974) Antibacterial activity of some C28 steroidal lactones. Indian J Pharm 36:122–123
Shanazbanu SS, Babu VLA, Dhanapal R (2006) Isolation of withaferin-A from Withania somnifera Dun. Leaves and its antibacterial activity. Asian J Chem 18:1243–1247
Sharma U, Velpandian T, Sharma P, Singh S (2009) Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties. Parasitol Res 105:1287–1293
Singh S, Kumar S (1998) Withania somnifera – the Indian ginseng Ashwagandha. Central Institute of Medicinal and Aromatic Plants, Lucknow
Singh G, Kumar P (2011) Evaluation of antimicrobial efficacy of flavonoids of Withania somnifera L. Indian J Pharm Sci 73:473–478
Srivastava P, Tiwari N, Yadav AK, Kumar V, Shanker K, Verma RK, Gupta MM, Gupta AK, Khanuja SP (2008) Simultaneous quantification of withano- lides in Withania somnifera by a validated high-performance thin-layer chromatographic method. J AOAC Int 91:1154–1161
Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, Sridhar P, Jayaprakasam B, Nair MG (2006) Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod 69:1790–1792
Subramanian SS, Sethi PD (1971) Steroidal lactone of Withania ashwagandha. Indian J Pharm 33:25–26
Sundaram S, Priyanka D, Shalini P (2011) In vitro evaluation of antibacterial activities of crude extracts of Withania somnifera (Ashwagandha) to bacterial pathogens. Asian J Biotechnol 3:194–199
Teixeira ST, Valadares MC, Goncalves SA, de Melo A, Queiroz MLS (2006) Prophylactic administration of Withania somnifera extract increases host resistance in Listeria monocytogenes infected mice. Int Immunopharmacol 6:1535–1542
Teklemariam Z (2005) In vivo evaluation of antimalarial activities of Moringa stenopetela, Withania somnifera and Vernonia amygdalina. MSc Thesis, Department of Biology, Addis Ababa University
The Wealth of India (1982) Publications and information directorate, Council of Scientific and Industrial Research (CSIR), New Delhi, pp 580–585
Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M (2010) Scientic basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: Ashwagandha. Cent Nerv Syst Agents Med Chem 10:238–246
Winters M (2006) Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev 11:269–277
Xu Y-m, Gao S, Bunting DP, Gunatilaka AAL (2011) Unusual withanolides from aeroponically grown Withania somnifera. Phytochemistry 72:518–522
Yamamoto ES, Campos BL, Laurenti MD, Lago JH, Grecco Sdos S, Corbett CE, Passero LF (2014) Treatment with triterpenic fraction purified from Baccharis Uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice. Parasitol Res 113:333–339
Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B (1996) Studies on the immunomodulatory effects of ashwagandha. J Ethnopharmacol 50:69–76
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Maurya, R. (2017). Withanolides: A Prospective Drug for Infectious and Tropical Diseases. In: Kaul, S., Wadhwa, R. (eds) Science of Ashwagandha: Preventive and Therapeutic Potentials. Springer, Cham. https://doi.org/10.1007/978-3-319-59192-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-59192-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59191-9
Online ISBN: 978-3-319-59192-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)